Stem cell protector for cancer treatment
Computer graphic of the molecular structure of a stem cell protector drug, BB10010, in development by British Biotechnology Ltd at the time of its demise in 2003. It was hoped that it would be an anticancer pharmaceutical which would protect bone marrow cells in chemotherapy patients.
Copyright © James King-Holmes Copyright © James King-Holmes |PLUS|01-AA-662|
Photo size: 17.5 Mpixels (50.2 MB uncompressed) - 4300x4078 pixels (14.3x13.5 in / 36.4x34.5 cm at 300 ppi)